Harvard research funding has become a critical topic as recent policies from the Trump administration have resulted in significant cuts, impacting the university’s scientific endeavors.Amidst the tumult, researchers at Harvard, such as Don Ingber from the Wyss Institute, are grappling with the abrupt halt of vital projects, particularly those leveraging innovative organ-on-a-chip technology.